Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-31

Clinical Trial Update: A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation [Phase 1]

View source ↗

Summary

This document reports on a Phase 1 clinical trial evaluating how Ziltivekimab behaves in Chinese adults with chronic kidney disease and systemic inflammation; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Chronic Kidney Disease and Systemic Inflammation | Phase 1 | Status: COMPLETED